Home > Insider Trading > Filing (0001209191-17-066069)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1435049	Aduro Biotech Inc.	ADRO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635616	G. Dirk Brockstedt	C/O Aduro Biotech, Inc. 740 Heinz Avenue Berkeley CA 94710	Evp Of Research And Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-15	64,108	$1.45	137,826	No	4	M	Direct
Common Stock	Disposition	2017-12-15	65,223	$8.11	72,603	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-12-15	64,108	$0.00	64,108	$1.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
225,998		2025-01-09	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.0 to $8.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015.